Business

Announcement on Voluntary Disclosure of Inclusion of Human Interferon α1b Inhalation Solution Being Included in the List of Drugs Granted Breakthrough Therapy Designation

Announcement on Voluntary Disclosure of Inclusion of Human Interferon α1b Inhalation Solution Being Included in the List of Drugs Granted Breakthrough Therapy Designation

articleKexing Biopharm Co., Ltd. Class ASeptember 23, 20254/news/announcement-on-voluntary-disclosure-of-inclusion-of-human-interferon-a1b-inhalation-solution-being-included-in-the-list-of-drugs-granted-breakthrough-therapy-designation
Announcement on Voluntary Disclosure of Inclusion of Human Interferon α1b Inhalation Solution Being Included in the List of Drugs Granted Breakthrough Therapy Designation

About this update from Kexing Biopharm Co., Ltd. Class A

Announcement on Voluntary Disclosure of Inclusion of Human Interferon α1b Inhalation Solution Being Included in the List of Drugs Granted Breakthrough Therapy DesignationThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Kexing Biopharm Co., Ltd. Class A